Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
30 results
- 1상모집 중· Healthy Volunteers건강한 사람에서 BMS-986533의 안전성, 약동학, 음식·pH 효과 및 약물상호작용 평가 연구
Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants
리드: BMS
- 1상모집 중· Healthy Volunteers건강한 성인 참가자에서 BMS-986521에 의한 M4 무스카린 아세틸콜린 수용체 점유도 평가를 위한 양전자방출단층촬영 연구
A Positron Emission Tomography Study to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants
리드: BMS
- 1상모집 중· Healthy Participants나블리메토스타트 정제 제형의 임상 1상 연구
A Phase 1 Study of Navlimetostat Tablet Formulations
리드: BMS
- 1상모집 중· Colorectal Cancer진행성 위장관암에서 DISP-10의 1상 임상시험
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
협력: BMS
- 1상모집 중· Diffuse Pleural MesotheliomaA Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
협력: BMS
- 1상모집 중· Rheumatoid ArthritisA Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis
리드: BMS
- 1상모집 중· Renal Cell CarcinomaA First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
리드: BMS
- 1상모집 중· Healthy VolunteersA Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.
리드: BMS
- 1상모집 중· Advanced Solid TumorsA Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in Participants With Advanced Solid Tumors
리드: BMS
- 1상모집 중· Refractory Autoimmune DiseasesA Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
리드: BMS
- 1상모집 중· SchizophreniaA Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
리드: BMS
- 1상모집 중· Multiple MyelomaA Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
협력: BMS
- 1상모집 중· Advanced Solid TumorA Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
리드: BMS
- 1상모집 중· Healthy VolunteersA Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, Explore the Effect of Food After Multiple Doses of Selected Prototypes, and Evaluate Alternative Formulations of KarX and KarXT Following Single and Multiple Ascending Doses
리드: BMS
- 1상모집 중· Advanced Malignant TumorsA Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
리드: BMS
- 1상모집 중· Advanced Solid Tumors With Homozygous MTAP DeletionA Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion
리드: BMS
- 1상모집 중· High-grade Serous Ovarian Carcinoma (HGSOC)A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
리드: BMS
- 1상모집 중· B-Cell Non-Hodgkin Lymphoma-RecurrentCC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma
협력: BMS
- 1상모집 중· Relapsed and/or Refractory Multiple MyelomaA Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
리드: BMS
- 1상모집 중· Metastatic Castration-resistant Prostate CancerA Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
리드: BMS
- 1상모집 중· Multiple MyelomaA Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
협력: BMS
- 1상모집 중· Solid TumorStudy of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
협력: BMS
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.